Medical science liaisons are engaging in broader conversations than ever before
The side-lining of efficacy in medical cannabis debates
Why doesn’t this apply to the drugs and devices that we use?
Abottom-up perspective on the development of international brands and campaigns
Search is ubiquitous, but what is pharma doing to assist in the user journey?
The problem with health insurance…
Is health insurance a rigged game?
The problematic link between patient satisfaction and healthcare funding
In challenging times pharma will benefit from a collaborative approach
In the 'healthcare spending crisis' it’s important to look beyond sensationalist headlines